0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Atracurium Besylate Injection Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-9Z19186
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Atracurium Besylate Injection Market Research Report 2025
BUY CHAPTERS

Global Atracurium Besylate Injection Market Research Report 2025

Code: QYRE-Auto-9Z19186
Report
March 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Atracurium Besylate Injection Market Size

The global market for Atracurium Besylate Injection was valued at US$ 785 million in the year 2024 and is projected to reach a revised size of US$ 995 million by 2031, growing at a CAGR of 3.3% during the forecast period.

Atracurium Besylate Injection Market

Atracurium Besylate Injection Market

Atracurium Besylate is a non-depolarizing neuromuscular blocking agent used in anesthesia to induce muscle relaxation during surgical procedures or mechanical ventilation. It works by blocking the transmission of nerve impulses to the muscles, preventing muscle contraction. As an injectable formulation, Atracurium Besylate is commonly administered intravenously (IV) in a hospital or surgical setting.
North American market for Atracurium Besylate Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Atracurium Besylate Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Atracurium Besylate Injection include Pfizer, Gland Pharma, American Remedies Healthcare, Flagship Biotech, Samarth Life Sciences, Lexicare Pharma, SGPharma, Qilu Pharma, Hengrui Medicine, GSK, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Atracurium Besylate Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atracurium Besylate Injection.
The Atracurium Besylate Injection market size, estimations, and forecasts are provided in terms of sales volume (L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Atracurium Besylate Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Atracurium Besylate Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Atracurium Besylate Injection Market Report

Report Metric Details
Report Name Atracurium Besylate Injection Market
Accounted market size in year US$ 785 million
Forecasted market size in 2031 US$ 995 million
CAGR 3.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 2.5ml:12.5mg
  • 5ml:25mg
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Gland Pharma, American Remedies Healthcare, Flagship Biotech, Samarth Life Sciences, Lexicare Pharma, SGPharma, Qilu Pharma, Hengrui Medicine, GSK, HBM Pharma, Centurion Healthcare
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Atracurium Besylate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Atracurium Besylate Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Atracurium Besylate Injection Market growing?

Ans: The Atracurium Besylate Injection Market witnessing a CAGR of 3.3% during the forecast period 2025-2031.

What is the Atracurium Besylate Injection Market size in 2031?

Ans: The Atracurium Besylate Injection Market size in 2031 will be US$ 995 million.

Who are the main players in the Atracurium Besylate Injection Market report?

Ans: The main players in the Atracurium Besylate Injection Market are Pfizer, Gland Pharma, American Remedies Healthcare, Flagship Biotech, Samarth Life Sciences, Lexicare Pharma, SGPharma, Qilu Pharma, Hengrui Medicine, GSK, HBM Pharma, Centurion Healthcare

What are the Application segmentation covered in the Atracurium Besylate Injection Market report?

Ans: The Applications covered in the Atracurium Besylate Injection Market report are Surgery, Medical Examination

What are the Type segmentation covered in the Atracurium Besylate Injection Market report?

Ans: The Types covered in the Atracurium Besylate Injection Market report are 2.5ml:12.5mg, 5ml:25mg

Recommended Reports

Anesthetics & Muscle Blockers

Myopathy & Nerve Disorders

Injection & Muscle Therapy

1 Atracurium Besylate Injection Market Overview
1.1 Product Definition
1.2 Atracurium Besylate Injection by Type
1.2.1 Global Atracurium Besylate Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 2.5ml:12.5mg
1.2.3 5ml:25mg
1.3 Atracurium Besylate Injection by Application
1.3.1 Global Atracurium Besylate Injection Market Value by Application (2024 VS 2031)
1.3.2 Surgery
1.3.3 Medical Examination
1.4 Global Atracurium Besylate Injection Market Size Estimates and Forecasts
1.4.1 Global Atracurium Besylate Injection Revenue 2020-2031
1.4.2 Global Atracurium Besylate Injection Sales 2020-2031
1.4.3 Global Atracurium Besylate Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Atracurium Besylate Injection Market Competition by Manufacturers
2.1 Global Atracurium Besylate Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Atracurium Besylate Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Atracurium Besylate Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Atracurium Besylate Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Atracurium Besylate Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Atracurium Besylate Injection, Product Type & Application
2.7 Global Key Manufacturers of Atracurium Besylate Injection, Date of Enter into This Industry
2.8 Global Atracurium Besylate Injection Market Competitive Situation and Trends
2.8.1 Global Atracurium Besylate Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Atracurium Besylate Injection Players Market Share by Revenue
2.8.3 Global Atracurium Besylate Injection Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Atracurium Besylate Injection Market Scenario by Region
3.1 Global Atracurium Besylate Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Atracurium Besylate Injection Sales by Region: 2020-2031
3.2.1 Global Atracurium Besylate Injection Sales by Region: 2020-2025
3.2.2 Global Atracurium Besylate Injection Sales by Region: 2026-2031
3.3 Global Atracurium Besylate Injection Revenue by Region: 2020-2031
3.3.1 Global Atracurium Besylate Injection Revenue by Region: 2020-2025
3.3.2 Global Atracurium Besylate Injection Revenue by Region: 2026-2031
3.4 North America Atracurium Besylate Injection Market Facts & Figures by Country
3.4.1 North America Atracurium Besylate Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Atracurium Besylate Injection Sales by Country (2020-2031)
3.4.3 North America Atracurium Besylate Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Atracurium Besylate Injection Market Facts & Figures by Country
3.5.1 Europe Atracurium Besylate Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Atracurium Besylate Injection Sales by Country (2020-2031)
3.5.3 Europe Atracurium Besylate Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Atracurium Besylate Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Atracurium Besylate Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Atracurium Besylate Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Atracurium Besylate Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Atracurium Besylate Injection Market Facts & Figures by Country
3.7.1 Latin America Atracurium Besylate Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Atracurium Besylate Injection Sales by Country (2020-2031)
3.7.3 Latin America Atracurium Besylate Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Atracurium Besylate Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Atracurium Besylate Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Atracurium Besylate Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Atracurium Besylate Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Atracurium Besylate Injection Sales by Type (2020-2031)
4.1.1 Global Atracurium Besylate Injection Sales by Type (2020-2025)
4.1.2 Global Atracurium Besylate Injection Sales by Type (2026-2031)
4.1.3 Global Atracurium Besylate Injection Sales Market Share by Type (2020-2031)
4.2 Global Atracurium Besylate Injection Revenue by Type (2020-2031)
4.2.1 Global Atracurium Besylate Injection Revenue by Type (2020-2025)
4.2.2 Global Atracurium Besylate Injection Revenue by Type (2026-2031)
4.2.3 Global Atracurium Besylate Injection Revenue Market Share by Type (2020-2031)
4.3 Global Atracurium Besylate Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Atracurium Besylate Injection Sales by Application (2020-2031)
5.1.1 Global Atracurium Besylate Injection Sales by Application (2020-2025)
5.1.2 Global Atracurium Besylate Injection Sales by Application (2026-2031)
5.1.3 Global Atracurium Besylate Injection Sales Market Share by Application (2020-2031)
5.2 Global Atracurium Besylate Injection Revenue by Application (2020-2031)
5.2.1 Global Atracurium Besylate Injection Revenue by Application (2020-2025)
5.2.2 Global Atracurium Besylate Injection Revenue by Application (2026-2031)
5.2.3 Global Atracurium Besylate Injection Revenue Market Share by Application (2020-2031)
5.3 Global Atracurium Besylate Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Atracurium Besylate Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Atracurium Besylate Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Gland Pharma
6.2.1 Gland Pharma Company Information
6.2.2 Gland Pharma Description and Business Overview
6.2.3 Gland Pharma Atracurium Besylate Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Gland Pharma Atracurium Besylate Injection Product Portfolio
6.2.5 Gland Pharma Recent Developments/Updates
6.3 American Remedies Healthcare
6.3.1 American Remedies Healthcare Company Information
6.3.2 American Remedies Healthcare Description and Business Overview
6.3.3 American Remedies Healthcare Atracurium Besylate Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 American Remedies Healthcare Atracurium Besylate Injection Product Portfolio
6.3.5 American Remedies Healthcare Recent Developments/Updates
6.4 Flagship Biotech
6.4.1 Flagship Biotech Company Information
6.4.2 Flagship Biotech Description and Business Overview
6.4.3 Flagship Biotech Atracurium Besylate Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Flagship Biotech Atracurium Besylate Injection Product Portfolio
6.4.5 Flagship Biotech Recent Developments/Updates
6.5 Samarth Life Sciences
6.5.1 Samarth Life Sciences Company Information
6.5.2 Samarth Life Sciences Description and Business Overview
6.5.3 Samarth Life Sciences Atracurium Besylate Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Samarth Life Sciences Atracurium Besylate Injection Product Portfolio
6.5.5 Samarth Life Sciences Recent Developments/Updates
6.6 Lexicare Pharma
6.6.1 Lexicare Pharma Company Information
6.6.2 Lexicare Pharma Description and Business Overview
6.6.3 Lexicare Pharma Atracurium Besylate Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Lexicare Pharma Atracurium Besylate Injection Product Portfolio
6.6.5 Lexicare Pharma Recent Developments/Updates
6.7 SGPharma
6.7.1 SGPharma Company Information
6.7.2 SGPharma Description and Business Overview
6.7.3 SGPharma Atracurium Besylate Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 SGPharma Atracurium Besylate Injection Product Portfolio
6.7.5 SGPharma Recent Developments/Updates
6.8 Qilu Pharma
6.8.1 Qilu Pharma Company Information
6.8.2 Qilu Pharma Description and Business Overview
6.8.3 Qilu Pharma Atracurium Besylate Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Qilu Pharma Atracurium Besylate Injection Product Portfolio
6.8.5 Qilu Pharma Recent Developments/Updates
6.9 Hengrui Medicine
6.9.1 Hengrui Medicine Company Information
6.9.2 Hengrui Medicine Description and Business Overview
6.9.3 Hengrui Medicine Atracurium Besylate Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Hengrui Medicine Atracurium Besylate Injection Product Portfolio
6.9.5 Hengrui Medicine Recent Developments/Updates
6.10 GSK
6.10.1 GSK Company Information
6.10.2 GSK Description and Business Overview
6.10.3 GSK Atracurium Besylate Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 GSK Atracurium Besylate Injection Product Portfolio
6.10.5 GSK Recent Developments/Updates
6.11 HBM Pharma
6.11.1 HBM Pharma Company Information
6.11.2 HBM Pharma Description and Business Overview
6.11.3 HBM Pharma Atracurium Besylate Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 HBM Pharma Atracurium Besylate Injection Product Portfolio
6.11.5 HBM Pharma Recent Developments/Updates
6.12 Centurion Healthcare
6.12.1 Centurion Healthcare Company Information
6.12.2 Centurion Healthcare Description and Business Overview
6.12.3 Centurion Healthcare Atracurium Besylate Injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Centurion Healthcare Atracurium Besylate Injection Product Portfolio
6.12.5 Centurion Healthcare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Atracurium Besylate Injection Industry Chain Analysis
7.2 Atracurium Besylate Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Atracurium Besylate Injection Production Mode & Process Analysis
7.4 Atracurium Besylate Injection Sales and Marketing
7.4.1 Atracurium Besylate Injection Sales Channels
7.4.2 Atracurium Besylate Injection Distributors
7.5 Atracurium Besylate Injection Customer Analysis
8 Atracurium Besylate Injection Market Dynamics
8.1 Atracurium Besylate Injection Industry Trends
8.2 Atracurium Besylate Injection Market Drivers
8.3 Atracurium Besylate Injection Market Challenges
8.4 Atracurium Besylate Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Atracurium Besylate Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Atracurium Besylate Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Atracurium Besylate Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Atracurium Besylate Injection Sales (L) of Key Manufacturers (2020-2025)
 Table 5. Global Atracurium Besylate Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Atracurium Besylate Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Atracurium Besylate Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Atracurium Besylate Injection Average Price (US$/mL) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Atracurium Besylate Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Atracurium Besylate Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Atracurium Besylate Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Atracurium Besylate Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Atracurium Besylate Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atracurium Besylate Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Atracurium Besylate Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Atracurium Besylate Injection Sales by Region (2020-2025) & (L)
 Table 18. Global Atracurium Besylate Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Atracurium Besylate Injection Sales by Region (2026-2031) & (L)
 Table 20. Global Atracurium Besylate Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Atracurium Besylate Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Atracurium Besylate Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Atracurium Besylate Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Atracurium Besylate Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Atracurium Besylate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Atracurium Besylate Injection Sales by Country (2020-2025) & (L)
 Table 27. North America Atracurium Besylate Injection Sales by Country (2026-2031) & (L)
 Table 28. North America Atracurium Besylate Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Atracurium Besylate Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Atracurium Besylate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Atracurium Besylate Injection Sales by Country (2020-2025) & (L)
 Table 32. Europe Atracurium Besylate Injection Sales by Country (2026-2031) & (L)
 Table 33. Europe Atracurium Besylate Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Atracurium Besylate Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Atracurium Besylate Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Atracurium Besylate Injection Sales by Region (2020-2025) & (L)
 Table 37. Asia Pacific Atracurium Besylate Injection Sales by Region (2026-2031) & (L)
 Table 38. Asia Pacific Atracurium Besylate Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Atracurium Besylate Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Atracurium Besylate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Atracurium Besylate Injection Sales by Country (2020-2025) & (L)
 Table 42. Latin America Atracurium Besylate Injection Sales by Country (2026-2031) & (L)
 Table 43. Latin America Atracurium Besylate Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Atracurium Besylate Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Atracurium Besylate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Atracurium Besylate Injection Sales by Country (2020-2025) & (L)
 Table 47. Middle East and Africa Atracurium Besylate Injection Sales by Country (2026-2031) & (L)
 Table 48. Middle East and Africa Atracurium Besylate Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Atracurium Besylate Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Atracurium Besylate Injection Sales (L) by Type (2020-2025)
 Table 51. Global Atracurium Besylate Injection Sales (L) by Type (2026-2031)
 Table 52. Global Atracurium Besylate Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Atracurium Besylate Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Atracurium Besylate Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Atracurium Besylate Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Atracurium Besylate Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Atracurium Besylate Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Atracurium Besylate Injection Price (US$/mL) by Type (2020-2025)
 Table 59. Global Atracurium Besylate Injection Price (US$/mL) by Type (2026-2031)
 Table 60. Global Atracurium Besylate Injection Sales (L) by Application (2020-2025)
 Table 61. Global Atracurium Besylate Injection Sales (L) by Application (2026-2031)
 Table 62. Global Atracurium Besylate Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Atracurium Besylate Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Atracurium Besylate Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Atracurium Besylate Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Atracurium Besylate Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Atracurium Besylate Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Atracurium Besylate Injection Price (US$/mL) by Application (2020-2025)
 Table 69. Global Atracurium Besylate Injection Price (US$/mL) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
 Table 73. Pfizer Atracurium Besylate Injection Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Gland Pharma Company Information
 Table 76. Gland Pharma Description and Business Overview
 Table 77. Gland Pharma Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
 Table 78. Gland Pharma Atracurium Besylate Injection Product
 Table 79. Gland Pharma Recent Developments/Updates
 Table 80. American Remedies Healthcare Company Information
 Table 81. American Remedies Healthcare Description and Business Overview
 Table 82. American Remedies Healthcare Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
 Table 83. American Remedies Healthcare Atracurium Besylate Injection Product
 Table 84. American Remedies Healthcare Recent Developments/Updates
 Table 85. Flagship Biotech Company Information
 Table 86. Flagship Biotech Description and Business Overview
 Table 87. Flagship Biotech Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
 Table 88. Flagship Biotech Atracurium Besylate Injection Product
 Table 89. Flagship Biotech Recent Developments/Updates
 Table 90. Samarth Life Sciences Company Information
 Table 91. Samarth Life Sciences Description and Business Overview
 Table 92. Samarth Life Sciences Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
 Table 93. Samarth Life Sciences Atracurium Besylate Injection Product
 Table 94. Samarth Life Sciences Recent Developments/Updates
 Table 95. Lexicare Pharma Company Information
 Table 96. Lexicare Pharma Description and Business Overview
 Table 97. Lexicare Pharma Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
 Table 98. Lexicare Pharma Atracurium Besylate Injection Product
 Table 99. Lexicare Pharma Recent Developments/Updates
 Table 100. SGPharma Company Information
 Table 101. SGPharma Description and Business Overview
 Table 102. SGPharma Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
 Table 103. SGPharma Atracurium Besylate Injection Product
 Table 104. SGPharma Recent Developments/Updates
 Table 105. Qilu Pharma Company Information
 Table 106. Qilu Pharma Description and Business Overview
 Table 107. Qilu Pharma Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
 Table 108. Qilu Pharma Atracurium Besylate Injection Product
 Table 109. Qilu Pharma Recent Developments/Updates
 Table 110. Hengrui Medicine Company Information
 Table 111. Hengrui Medicine Description and Business Overview
 Table 112. Hengrui Medicine Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
 Table 113. Hengrui Medicine Atracurium Besylate Injection Product
 Table 114. Hengrui Medicine Recent Developments/Updates
 Table 115. GSK Company Information
 Table 116. GSK Description and Business Overview
 Table 117. GSK Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
 Table 118. GSK Atracurium Besylate Injection Product
 Table 119. GSK Recent Developments/Updates
 Table 120. HBM Pharma Company Information
 Table 121. HBM Pharma Description and Business Overview
 Table 122. HBM Pharma Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
 Table 123. HBM Pharma Atracurium Besylate Injection Product
 Table 124. HBM Pharma Recent Developments/Updates
 Table 125. Centurion Healthcare Company Information
 Table 126. Centurion Healthcare Description and Business Overview
 Table 127. Centurion Healthcare Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
 Table 128. Centurion Healthcare Atracurium Besylate Injection Product
 Table 129. Centurion Healthcare Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Atracurium Besylate Injection Distributors List
 Table 133. Atracurium Besylate Injection Customers List
 Table 134. Atracurium Besylate Injection Market Trends
 Table 135. Atracurium Besylate Injection Market Drivers
 Table 136. Atracurium Besylate Injection Market Challenges
 Table 137. Atracurium Besylate Injection Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Atracurium Besylate Injection
 Figure 2. Global Atracurium Besylate Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Atracurium Besylate Injection Market Share by Type: 2024 & 2031
 Figure 4. 2.5ml:12.5mg Product Picture
 Figure 5. 5ml:25mg Product Picture
 Figure 6. Global Atracurium Besylate Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Atracurium Besylate Injection Market Share by Application: 2024 & 2031
 Figure 8. Surgery
 Figure 9. Medical Examination
 Figure 10. Global Atracurium Besylate Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Atracurium Besylate Injection Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Atracurium Besylate Injection Sales (2020-2031) & (L)
 Figure 13. Global Atracurium Besylate Injection Average Price (US$/mL) & (2020-2031)
 Figure 14. Atracurium Besylate Injection Report Years Considered
 Figure 15. Atracurium Besylate Injection Sales Share by Manufacturers in 2024
 Figure 16. Global Atracurium Besylate Injection Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Atracurium Besylate Injection Players: Market Share by Revenue in Atracurium Besylate Injection in 2024
 Figure 18. Atracurium Besylate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Atracurium Besylate Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Atracurium Besylate Injection Sales Market Share by Country (2020-2031)
 Figure 21. North America Atracurium Besylate Injection Revenue Market Share by Country (2020-2031)
 Figure 22. United States Atracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Atracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Atracurium Besylate Injection Sales Market Share by Country (2020-2031)
 Figure 25. Europe Atracurium Besylate Injection Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Atracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Atracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Atracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Atracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Atracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Atracurium Besylate Injection Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Atracurium Besylate Injection Revenue Market Share by Region (2020-2031)
 Figure 33. China Atracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Atracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Atracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Atracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Atracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Atracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Atracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Atracurium Besylate Injection Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Atracurium Besylate Injection Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Atracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Atracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Atracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Colombia Atracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Atracurium Besylate Injection Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Atracurium Besylate Injection Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Atracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Atracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Atracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Atracurium Besylate Injection by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Atracurium Besylate Injection by Type (2020-2031)
 Figure 53. Global Atracurium Besylate Injection Price (US$/mL) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Atracurium Besylate Injection by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Atracurium Besylate Injection by Application (2020-2031)
 Figure 56. Global Atracurium Besylate Injection Price (US$/mL) by Application (2020-2031)
 Figure 57. Atracurium Besylate Injection Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension